Company Filing History:
Years Active: 2025
Title: Matthieu Ravelingien: Innovator in Pharmaceutical Compositions
Introduction
Matthieu Ravelingien is a notable inventor based in Geel, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on compositions that include aticaprant. His expertise and dedication to research have led to the development of valuable medical solutions.
Latest Patents
Ravelingien holds a patent for "Compositions comprising aticaprant." This patent focuses on oral compositions in the form of tablets that incorporate aticaprant and outlines methods for their use. His work in this area demonstrates a commitment to advancing pharmaceutical formulations that can improve patient outcomes.
Career Highlights
Matthieu Ravelingien is currently employed at Janssen Pharmaceuticals, Inc., a leading company in the pharmaceutical industry. His role at Janssen allows him to collaborate with other experts and contribute to groundbreaking research and development in medicine.
Collaborations
Ravelingien has worked alongside talented colleagues, including Nicolaas Martha Felix Goyvaerts and Mark Schmidt. These collaborations have fostered an environment of innovation and creativity, leading to advancements in pharmaceutical compositions.
Conclusion
Matthieu Ravelingien's contributions to the field of pharmaceuticals, particularly through his patent on aticaprant compositions, highlight his role as an influential inventor. His work at Janssen Pharmaceuticals and collaborations with esteemed colleagues further emphasize his commitment to improving healthcare solutions.